LAUREN SELBERG: Open Payments
NPI 1043984800 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$446 in 23 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $579 · 2025 $446
Food & beverage: $446
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $114 |
| PFIZER INC. | 3 | $67 |
| Sumitomo Pharma America, Inc. | 3 | $62 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Lilly USA, LLC | 3 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $18 |
Products named: Wegovy, GEMTESA, TRELEGY ELLIPTA, PREVNAR 20, MOUNJARO, FARXIGA, INSPIRE, NURTEC ODT.
Industry payments across OK — which companies pay providers there.
